Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1994-01-12
1997-02-11
Bleutge, John C.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
128898, 128899, 424422, 424423, 424486, 424487, 435182, A61F 200, A61K 900
Patent
active
056018355
ABSTRACT:
Disclosed is a polymeric drug delivery system for delivery of any substance to the central nervous system. The delivery system is preferably implanted in the central nervous system for delivery of the drug directly to the central nervous system. These implantable devices can be used, for example, to achieve continuous delivery of dopamine, which cannot pass the blood brain barrier, directly into the brain for an extended time period. The implantable devices display controlled, "zero-order" release kinetics, a life time of a minimum of several weeks or months even when the devices contain water soluble, low molecular weight compounds, biocompatibility, and relative non-invasiveness. The polymeric devices are applicable in the treatment of a variety of central nervous system disorders including Parkinson's disease, Alzheimer's dementia, Huntington's disease, epilepsy, trauma, stroke, depression and other types of neurological and psychiatric illnesses.
REFERENCES:
patent: 3625214 (1971-12-01), Higuchi
patent: 3832252 (1974-08-01), Higuchi
patent: 3880991 (1975-04-01), Yolles
patent: 3948254 (1976-04-01), Zaffaroni
patent: 3965255 (1976-06-01), Block et al.
patent: 3976071 (1976-08-01), Sadek
patent: 4069307 (1978-01-01), Higuchi
patent: 4164560 (1979-08-01), Folkman et al.
patent: 4177256 (1979-12-01), Michaels
patent: 4217898 (1980-08-01), Theeuwas
patent: 4263273 (1981-04-01), Appelgren et al.
patent: 4278087 (1981-07-01), Theeuwes
patent: 4346709 (1982-08-01), Schmitt
patent: 4351337 (1982-09-01), Sidman
patent: 4391797 (1983-07-01), Folkman et al.
patent: 4675189 (1987-06-01), Kent et al.
patent: 4832686 (1989-05-01), Anderson
patent: 4832957 (1989-05-01), Dempski et al.
patent: 4883666 (1989-11-01), Sabel et al.
patent: 4913903 (1990-04-01), Sudmann et al.
patent: 4952402 (1990-08-01), Sparks et al.
patent: 4983400 (1991-01-01), Dempski et al.
patent: 5019372 (1991-05-01), Folkman et al.
patent: 5106627 (1992-04-01), Aebischer et al.
patent: 5114719 (1992-05-01), Sabel et al.
patent: 5156844 (1992-10-01), Aebischer et al.
A. D. Schwope, et al. Chemical Abstrcts 84, 304 Abstract No. 84:184849x.
R. Willette, Chemical Abstracts 84(13) 304 Abstract No. 184855w (Jun. 28, 1976).
Suzuki and Price Journal of Pharmaceutical Sciences 74(1) 21-24 (Jan. 1985).
Cardinal, "Matrix Systems", Chapter 2, Medical Applications of Controlled Release, vol. 1, 41-67, 87-89 (CRC Press, Inc., Florida 1984).
Siegel, R. A., et al., Pharm. Res. 1, 2-10 (1984).
Boer, et al., J. Neuroscience Methods 11, 281-289 (Elsevier: The Netherlands, 1984).
McRae-Degueurce, et al., Neuroscience Letters (Ireland) 92(3), 303-309 (1988).
Sladek, et al, J. Neurosurg. 68,337-351 (1981).
Cotzias, et al, New Eng. J. Med. 276(7) 374-379 (Feb. 16, 1967).
Yahr, et al, Arch. Neurol. 21,343-354 (Oct. 1969).
Rossor, et al, J. Neurolog. Sci. 46,385-392 (1980).
Gonzalez, et al., Abstracts Soc. Neuroscience No. 353,15 (1988).
Juncos, et al, J. Neurol. Neurosurg. Psych. 50, 194-198 (1987).
Quinn, et al, Lancet 412-415 (Aug. 21, 1982).
Shoulson, Neurol. 25,1144-1148 (Dec. 1975).
Cedarbaum, Neruol. 37,1607-1612 (Oct. 1987).
Mouradian, et al, Ann. Neurol. 22,475-479 (1987).
Martin, JAMA 216(12),1979-1983 (Jun. 21, 1971).
Tolosa, et al, Neurol. 25,177-183 (Feb. 1975).
Nutt, Ann. Neurol. 22, 535-540 (Mar. 3, 1987).
Mars, Arch. Neurol. 28,91 (Feb. 1973).
Juncos, et al, Arch Neurol. 44,1010-1012 (Oct. 1987).
Bergmann, et al, Adv. Neurol. 45,463-467 (1986).
Brady, Molecular Basis of Lysosomal Storage Disorders 461-474 (Academic Press 1984).
Pincus, et al, Arch.Neurol. 44,1006-1009 (1987).
Saarinen, et al, Acta Neurol. Scandinav. 58,340-349 (1978).
Birket-Smith, et al, Lancet 431-432 (Feb. 24, 1973).
Cedarbaum, et al, Neurol. 37,233-241 (1987).
Curzon, et al, Lancet 781 (Apr. 7, 1973).
Woods, et al, Lancet 1391 (Jun. 16, 1973).
Chase, et al, Adv. in Neurol. 45,477-480 (1986).
Brown, L., et al., "Controlled Release of Insulin From Polymer Matrices-Control of Diabetes in Rats" Diabetes, vol. 35, pp. 692-697 (Jun., 1966).
Brown, L., et al., "Controlled Release of Insulin from Polymer Matrices-In Vitro Kinetics", Diabetes, vol. 35, No. 6, pp. 684-691 (Jun., 1966).
Hsieh, D. S., et al., "Zero-Order Controlled-Release Polymer Matrices for Micro-and Macromolecules" Journal of Pharmaceutical Sciences, vol. 72, No. 1, pp. 17-22 (Jan., 1983).
During Matthew J.
Freese Andrew
Sabel Bernhard A.
Saltzman William M.
Bleutge John C.
Harrison Robert H.
Massachusetts Institute of Technology
LandOfFree
Polymeric device for controlled drug delivery to the CNS does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymeric device for controlled drug delivery to the CNS, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymeric device for controlled drug delivery to the CNS will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-339843